Genetic diversity and seroprevalence of Toxoplasma gondii in COVID19 patients; a first case-control study in Iran … – BMC Infectious Diseases

Dubey J, Jones J. Toxoplasma gondii infection in humans and animals in the United States. Int J Parasitol. 2008;38(11):125778.

Article CAS PubMed Google Scholar

Daryani A, Sarvi S, Aarabi M, Mizani A, Ahmadpour E, Shokri A, Rahimi M-T, Sharif M. Seroprevalence of Toxoplasma Gondii in the Iranian general population: a systematic review and meta-analysis. Acta Trop. 2014;137:18594.

Article PubMed Google Scholar

Webster JP. Review of Toxoplasmosis of animals and humans by JP Dubey. Parasites & Vectors. 2010;3:112.

Article Google Scholar

Ali MI, Abd El Wahab WM, Hamdy DA, Hassan A. Toxoplasma Gondii in cancer patients receiving chemotherapy: seroprevalence and interferon gamma level. J Parasitic Dis. 2019;43:46471.

Article Google Scholar

Shams A-DE, Awad AHH. Seroprevalence of toxoplasma gondii in immunocompromised cancer patients in Basrah Provence, Southern Iraq. J Basrah Res(Sci). 2022;48(2):5764.

Google Scholar

Shaw T, El-Taweel H, Gammal M, Khali S, Ibrahim H. Toxoplasmosis in adult patients with haematologic malignancy: seroprevalence of anti-toxoplasma antibodies and molecular diagnosis. Parasitologists United Journal. 2023;16(1):7986.

Article Google Scholar

Shapira Y, Agmon-Levin N, Selmi C, Petrkov J, Barzilai O, Ram M, Bizzaro N, Valentini G, Matucci-Cerinic M, Anaya J-M. Prevalence of anti-toxoplasma antibodies in patients with autoimmune diseases. J Autoimmun. 2012;39(12):1126.

Article CAS PubMed Google Scholar

Lidar M, Langevitz P, Shoenfeld Y. The role of Infection in inflammatory bowel disease: initiation, exacerbation and protection. Isr Med Association Journal: IMAJ. 2009;11(9):55863.

Google Scholar

Vittecoq M, Elguero E, Lafferty KD, Roche B, Brodeur J, Gauthier-Clerc M, Miss D, Thomas F. Brain cancer mortality rates increase with Toxoplasma gondii seroprevalence in France. Infect Genet Evol. 2012;12(2):4968.

Article PubMed Google Scholar

Thomas F, Lafferty KD, Brodeur J, Elguero E, Gauthier-Clerc M, Miss D. Incidence of adult brain cancers is higher in countries where the protozoan parasite Toxoplasma gondii is common. Biol Lett. 2012;8(1):1013.

Article PubMed Google Scholar

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus Pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):50713.

Article CAS Google Scholar

Konala VM, Adapa S, Gayam V, Naramala S, Daggubati SR, Kammari CB, Chenna A. Co-infection with Influenza A and COVID-19. Eur J case Rep Intern Med 2020, 7(5).

Zhu X, Ge Y, Wu T, Zhao K, Chen Y, Wu B, Zhu F, Zhu B, Cui L. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res. 2020;285:198005.

Article CAS PubMed Google Scholar

Pemn J, Ruiz-Gaitn A, Garca-Vidal C, Salavert M, Ramrez P, Puchades F, Garca-Hita M, Alastruey-Izquierdo A, Quinds G. Fungal co-infection in COVID-19 patients: should we be concerned? Revista Iberoamericana De Micologia. 2020;37(2):416.

Article PubMed PubMed Central Google Scholar

Sharaf-El-Deen SA. Toxoplasma Gondii as a possible risk factor for COVID-19 severity: a case-control study. Egypt J Med Microbiol. 2021;30(2):12532.

Article Google Scholar

Flegr J. Toxoplasmosis is a risk factor for acquiring SARS-CoV-2 Infection and a severe course of COVID-19 in the Czech and Slovak population: a preregistered exploratory internet cross-sectional study. Parasites & Vectors. 2021;14(1):111.

Article Google Scholar

Montazeri M, Nakhaei M, Fakhar M, Pazoki H, Pagheh AS, Nazar E, Zakariaei Z, Mirzaeian H, Sharifpour A, Banimostafavi ES. Exploring the Association between Latent Toxoplasma Gondii Infection and COVID-19 in hospitalized patients: First Registry-based study. Acta Parasitol 2022:18.

Roe K. A role for T-cell exhaustion in Long COVID19 and severe outcomes for several categories of COVID19 patients. J Neurosci Res. 2021;99(10):236776.

Article CAS PubMed PubMed Central Google Scholar

Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol 2021:1494.

Abdel-Hamed EF, Ibrahim MN, Mostafa NE, Moawad HS, Elgammal NE, Darwiesh EM, El-Rafey DS, ElBadawy NE, Al-Khoufi EA, Hindawi SI. Role of interferon gamma in SARS-CoV-2-positive patients with parasitic Infections. Gut Pathogens. 2021;13(1):17.

Article Google Scholar

Jankowiak , Rozsa L, Tryjanowski P, Mller AP. A negative covariation between toxoplasmosis and CoVID-19 with alternative interpretations. Sci Rep. 2020;10(1):17.

Article Google Scholar

Bhadra R, Gigley JP, Weiss LM, Khan IA. Control of Toxoplasma reactivation by rescue of dysfunctional CD8+T-cell response via PD-1PDL-1 blockade. Proc Natl Acad Sci. 2011;108(22):9196201.

Article CAS PubMed PubMed Central Google Scholar

Erol MK, Bozdogan YC, Suren E, Gedik B. Treatment of a full-thickness macular hole and retinal detachment secondary to toxoplasma chorioretinitis that developed shortly after COVID-19: a case report. J Fr Ophtalmol 2022.

Lecordier L, Moleon-Borodowsky I, Dubremetz J-F, Tourvieille B, Mercier C, Desle D, Capron A, Cesbron-Delauw M-F. Characterization of a dense granule antigen of Toxoplasma Gondii (GRA6) associated to the network of the parasitophorous vacuole. Mol Biochem Parasitol. 1995;70(12):8594.

Article CAS PubMed Google Scholar

Fallahi S, Rostami A, Birjandi M, Zebardast N, Kheirandish F, Spotin A. Parkinsons Disease and Toxoplasma Gondii Infection: sero-molecular assess the possible link among patients. Acta Trop. 2017;173:97101.

Article PubMed Google Scholar

Parsaei M, Spotin A, Matini M, Mahjub H, Aghazadeh M, Ghahremani G, Taherkhani H. Prevalence of toxoplasmosis in patients infected with Tuberculosis; a sero-molecular case-control study in northwest Iran. Comp Immunol Microbiol Infect Dis. 2022;81:101720.

Article CAS PubMed Google Scholar

Rozas J, Snchez-DelBarrio JC, Messeguer X, Rozas R. DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics. 2003;19(18):24967.

Article CAS PubMed Google Scholar

Geraili A, Badirzadeh A, Sadeghi M, Mousavi SM, Mousavi P, Shahmoradi Z, Hosseini S-M, Hejazi SH, Rafiei-Sefiddashti R. Toxoplasmosis and symptoms severity in patients with COVID-19 in referral centers in Northern Iran. J Parasitic Dis. 2023;47(1):18591.

Article Google Scholar

Roe K. The symptoms and clinical manifestations observed in COVID-19 patients/long COVID-19 symptoms that parallel Toxoplasma Gondii Infections. J Neuroimmune Pharmacol. 2021;16(3):5136.

Article PubMed PubMed Central Google Scholar

Roe K. The link between Toxoplasma gondii Infections and higher mortality in COVID-19 patients having schizophrenia. Eur Arch Psychiatry Clin NeuroSci 2021:12.

Galvn-Ramrez ML, Salas-Lais AG, Muoz-Medina JE, Fernandes-Matano L, Prez LRR. Franco De Len K: Association of Toxoplasmosis and COVID-19 in a Mexican Population. Microorganisms. 2023;11(6):1441.

Article PubMed PubMed Central Google Scholar

Xiao J, Prandovszky E, Kannan G, Pletnikov MV, Dickerson F, Severance EG, Yolken RH. Toxoplasma Gondii: biological parameters of the connection to schizophrenia. Schizophr Bull. 2018;44(5):98392.

Article PubMed PubMed Central Google Scholar

Hirsch CS, Ellner JJ, Blinkhorn R, Toossi Z. In vitro restoration of T cell responses in Tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor . Proc Natl Acad Sci. 1997;94(8):392631.

Article CAS PubMed PubMed Central Google Scholar

Roe K. The role of polyspecific T-cell exhaustion in severe outcomes for COVID-19 patients having latent pathogen Infections such as Toxoplasma Gondii. Microb Pathog. 2021;161:105299.

Article CAS PubMed PubMed Central Google Scholar

Osokine I, Snell LM, Cunningham CR, Yamada DH, Wilson EB, Elsaesser HJ, de la Torre JC, Brooks D. Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral Infection. Proc Natl Acad Sci. 2014;111(20):740914.

Article CAS PubMed PubMed Central Google Scholar

Siles-Lucas M, Gonzlez-Miguel J, Geller R, Sanjuan R, Prez-Arvalo J, Martnez-Moreno . Potential influence of helminth molecules on COVID-19 pathology. Trends Parasitol. 2021;37(1):114.

Article CAS PubMed Google Scholar

See the article here:

Genetic diversity and seroprevalence of Toxoplasma gondii in COVID19 patients; a first case-control study in Iran ... - BMC Infectious Diseases